Now I have all the information needed. Let me produce the final consolidated review.

## Summary

This paper proposes scDiff, a conditional diffusion generative model that unifies diverse single-cell analysis tasks (cell labeling, expression completion, and knowledge transfer) under a single posterior estimation framework $p(\mathbf{X}|\mathbf{C})$. By framing tasks as conditional posterior estimation and using a modular architecture with cross-attention conditioners, scDiff achieves competitive or state-of-the-art results across multiple benchmarks using one unified training objective. The paper further demonstrates that external prior knowledge (from LLMs for cell type descriptions, or GNNs for gene-gene relationships) can be plugged into the conditioner module to enable few-shot and zero-shot transfer.

## Strengths

- **Principled unified formulation of diverse single-cell tasks.** The paper formalizes cell type annotation, missing value imputation, and perturbation prediction as posterior estimation problems under a single objective $p(\mathbf{X}|\mathbf{C})$ (Section 2.1). This is a clean conceptual departure from prior task-specific architectures, and the derivations (Eq. 1–4) are clearly articulated.

- **Competitive performance across multiple benchmarks with a single architecture.** Using the same scDiff architecture and training objective, the model achieves top-2 macro accuracy on 4/6 cell-type annotation datasets (Table 1), matches or exceeds MAGIC on imputation (Table 2a), and outperforms all baselines on perturbation prediction for novel cell types across all three datasets with clear margins (Table 2b). All results are reported with means and standard deviations across five runs.

- **Modular conditioner design enabling external knowledge integration.** The cross-attention-based conditioner module cleanly separates the generative backbone from the conditioning source. The paper demonstrates this flexibility with two distinct external priors (BioLinkBERT for cell type semantics, GEARS-derived GNN for gene relationships) without modifying the core diffusion process. The one-shot experiments (Figure 2) show that the LLM conditioner improves over the class-conditioned variant on 3/4 datasets, and the zero-shot experiments (Figure 3) show scDiff outperforming GEARS on 5/6 metrics with lower variance.

- **Strongest evidence comes from perturbation prediction for novel cell types (Section 4.1.3).** scDiff outperforms all baselines (scGen, CVAE, CPA, PCA-Vec, Vec) on all three datasets with substantial margins. This is the paper's most convincing experimental result, demonstrating clear practical utility for a challenging transfer task.

## Weaknesses

### Fatal
None.

### Major

- **Missing architecture-matched VAE ablation undermines attribution of gains to diffusion.** The paper compares scDiff against scVI (a VAE with a different architecture—negative binomial decoder, no cross-attention) but not against a VAE with the same modular architecture (same cross-attention encoder, same linear decoder, same conditioners, trained with a VAE objective). Without this ablation, performance advantages could plausibly stem from the architectural choices (cross-attention conditioning, predict-$x_0$ parameterization, linear decoder) rather than from the diffusion process itself. This is the most significant gap in the paper's experimental validation: the central claim that conditional diffusion is particularly well-suited for single-cell posterior estimation remains unsupported by direct evidence. The perturbation results (Section 4.1.3) are the strongest indicator of value, but even there it is unclear how much the diffusion process contributes vs. the architecture.

- **Failure of predict-$\epsilon$ is claimed as an empirical finding but shown with zero empirical evidence.** Section 2.2 states: *"We empirically find that the widely-used predict-$\epsilon$ objective fails to recover the expression. Since single-cell data often shows extreme sparsity... the corrupted input... will mostly be pure noise. Under predict-$\epsilon$ parameterization, the model would likely learn to reverse the noise schedule instead of modeling the data posterior."* Despite claiming an *empirical* finding, no experiment, ablation, or comparison of predict-$\epsilon$ vs. predict-$x_0$ is presented anywhere in the paper. The quoted language ("would likely learn") is speculative. If predict-$\epsilon$ works adequately, this design justification collapses. A simple ablation on one dataset would resolve this.

- **Few-shot and zero-shot experiments lack sufficient baselines to support the claimed strength.** For one-shot cell type annotation (Section 4.2.1, Figure 2), the baselines consist only of CellTypist (logistic regression) and the self-comparison with scDiff-class. There is no simple classifier that uses BioLinkBERT embeddings directly (to isolate the value of the diffusion model from the LLM prior), no few-shot learning methods (prototypical networks, k-nearest-neighbor in gene space), and no fine-tuned linear probe on pretrained VAE features. For zero-shot perturbation (Section 4.2.2, Figure 3), the only baseline is GEARS itself. While the scDiff-vs-GEARS comparison is informative (scDiff uses GEARS's prior + its own diffusion backbone), additional baselines (e.g., scGen with the same GNN prior, a linear model on GNN embeddings) would strengthen the claim that the diffusion backbone drives the improvement. The paper's language ("outstanding few-shot and zero-shot results") is not commensurate with the thin baseline set.

### Minor

- **The "general framework" claim is broader than the experimental validation.** Section 2.1 lists cell trajectory inference, spatial deconvolution, missing gene imputation, multiomics modality prediction, and drug perturbation prediction as tasks the framework addresses, but none are experimentally evaluated. The paper tests one representative from each of the three task categories (cell type annotation, missing value imputation, perturbation prediction for novel cell types), which is reasonable scope for a single paper, but the framing as a "general framework" oversells the validated breadth.

### Trivial
None.

## Nice-to-Haves

- A predict-$\epsilon$ vs. predict-$x_0$ ablation on at least one dataset would convert a speculative design justification into an evidence-backed contribution.
- For one-shot annotation, adding a simple baseline that classifies using BioLinkBERT embeddings directly (e.g., a nearest-centroid or linear probe) would help isolate the benefit of the diffusion process from the value of the LLM prior.
- Reporting per-cell-type accuracy breakdowns for the one-shot experiment (rather than only macro accuracy) would clarify which rare cell types benefit from the LLM conditioner.

## Removed Points

These points are flagged to be removed; treat them with caution:

- **"The only baseline is CellTypist" for one-shot annotation.** The paper also compares scDiff-LLM against scDiff-class (the class-conditioned variant), so this claim is factually incomplete. The underlying concern (thin baselines) is retained in the major weaknesses above.
- **Criticism about missing hyperparameters (T, $\beta_t$, number of layers, hidden dimensions).** These details are standard for the appendix, which was stripped by the parser. The original submission likely contains them.
- **Strength Finder's claim that predict-$x_0$ is "justified empirically."** The paper states "We empirically find" but provides no empirical evidence. This strength conflicts with a verified weakness and is removed per the rules.
- **Criticism about formatting/style nitpicks** — these are parser artifacts, not author errors.

## Novel Insights

None beyond the paper's own contributions. The reviews do not surface a genuinely novel observation that the authors themselves missed.

## Suggestions

1. **Add an architecture-matched VAE ablation.** Train a conditional VAE using the same cross-attention encoder, linear decoder, and conditioner modules as scDiff, differing only in the training objective (ELBO with a reparameterized latent variable vs. diffusion). Compare on at least one task per category (e.g., cell type annotation on PBMC12K, imputation on Jurkat, perturbation on Salmonella). This single experiment would determine whether the diffusion process provides measurable benefit over a simpler generative model with the same conditioning architecture.

2. **Add a predict-$\epsilon$ ablation.** Train scDiff with the predict-$\epsilon$ objective on one dataset and show that it performs worse. This is a one-line change in the training code and would convert a speculative design claim into an evidence-backed contribution.

3. **Strengthen few-shot baselines.** For one-shot annotation, add a classifier that uses BioLinkBERT embeddings as input to a logistic regression or MLP (no diffusion). For zero-shot perturbation, add a linear model or scGen using the same GNN embeddings. This would isolate the contribution of the diffusion backbone from the value of the prior encoding.

4. **Tone down the "outstanding" / "general framework" language** to match the evidence. The results are competitive and promising, but the paper's strongest claims ("outstanding few-shot and zero-shot results," "general framework" for tasks that are listed but not tested) are not fully supported by the experiments presented.

5. **Clarify the annotation procedure.** The paper states that annotation is done by "evaluating the mean square error between input expression and model posterior in a classifier-free approach (Li et al., 2023)" — this is vague. Specify exactly how the conditional likelihood is computed for each candidate class and how the argmax is derived.

## Score and Decision

**Overall assessment:** The paper makes a genuine conceptual contribution (unifying diverse single-cell tasks under conditional posterior estimation) and demonstrates competitive results across multiple benchmarks with a single architecture. The modular conditioner design is a practical strength. However, two significant experimental gaps—the missing architecture-matched VAE ablation and the unsubstantiated predict-$\epsilon$ claim—prevent the paper from fully supporting its central claims about the value of the diffusion process. The few-shot/zero-shot results are promising but under-baselined. These weaknesses are addressable (they require additional experiments, not a rewrite of the paper), but they are substantive enough that the paper should not be accepted in its current form. The paper is on the right track and would benefit from a round of revision with the suggested ablations.

**MY FINAL SCORE: <pineapple>6.0</pineapple>**
**MY FINAL DECISION: <orange>Reject</orange>**